Katie Dunkel
Family · Clarksville, ARNPI 1447485727
Payments from drug & device makers
Across 99 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$486
- Lilly USA, LLC$160
- Pfizer$142
- Novo Nordisk$128
- AstraZeneca$99
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$78
- plus $459 from 18 others
What the payments were for
- Food & beverage$1,551100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $486 |
| Lilly USA, LLC | 11 | $160 |
| Pfizer | 8 | $142 |
| Novo Nordisk | 7 | $128 |
| AstraZeneca | 5 | $99 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $78 |
| Boehringer Ingelheim | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Abbott | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Johnson & Johnson | 2 | $29 |
| Boston Scientific | 2 | $28 |
| Procept Biorobotics Corporation | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Novartis | 1 | $18 |
| GSK | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $11 |
How this compares
$1,551 in reported general payments places this provider in the 75th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $66,451 |
| MounjaroTirzepatide | 42 | $48,699 |
| JanuviaSitagliptin Phosphate | 38 | $35,020 |
| JardianceEmpagliflozin | 19 | $19,127 |
| FarxigaDapagliflozin Propanediol | 16 | $18,381 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $17,657 |
| EliquisApixaban | 18 | $7,258 |
| Risperdal ConstaRisperidone Microspheres | 11 | $6,649 |
| ZenpepLipase/Protease/Amylase | 16 | $6,030 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,462 |
| Gabapentin | 104 | $2,069 |
| Febuxostat | 13 | $1,644 |
| Omeprazole | 91 | $1,356 |
| Cyclobenzaprine Hcl | 58 | $1,107 |
| Atorvastatin Calcium | 163 | $996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $128 | $66,45169 claims |
| Lilly USA, LLCMounjaro | $160 | $48,69942 claims |
| Boehringer IngelheimJardiance | $52 | $19,12719 claims |
| AstraZenecaFarxiga | $99 | $18,38116 claims |
| PfizerEliquis | $142 | $7,25818 claims |
| Johnson & JohnsonRisperdal Consta | $29 | $6,64911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,103 family providers in Arkansas.
Other family in Clarksville
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.